A comparison of capture antibody fragments in cardiac troponin I immunoassay

Clinical Biochemistry

Volumn 46, Issue 12, 2013, Pages 963-968

  Hyytiä, Heidi ^a   Järvenpää, Marja Leena ^a   Ristiniemi, Noora ^a   Lövgren, Timo ^a   Pettersson, Kim ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Antibody fragment; Cardiac troponin I; Heterophilic antibody; Human anti mouse antibodies; Immunoassay; Nanoparticle

Indexed keywords

EUROPIUM; HEPARIN; IMMOBILIZED ANTIBODY; IMMUNOGLOBULIN F(AB) FRAGMENT; NANOPARTICLE; STREPTAVIDIN; TROPONIN I;

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CLINICAL ASSESSMENT; CONTROLLED STUDY; FLUOROMETRY; HUMAN; IMMUNOASSAY; KINETICS; LIMIT OF DETECTION; NORMAL HUMAN; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ANTIBODY FRAGMENT; CARDIAC TROPONIN I; HETEROPHILIC ANTIBODY; HUMAN ANTI-MOUSE ANTIBODIES; IMMUNOASSAY; NANOPARTICLE;

ADULT; CALIBRATION; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN FRAGMENTS; KINETICS; MIDDLE AGED; MYOCARDIUM; TROPONIN I; YOUNG ADULT;

EID: 84880585856     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.01.012     Document Type: Article

References (33)

1. Kricka L.J. Human anti-animal antibody interferences in immunological assays. Clin Chem 1999, 45:942-956.
2. Tate J., Ward G. Interferences in immunoassay. Clin Biochem Rev 2004, 25:105-120.
3. Bjerner J., Olsen K.H., Børmer O.P., Nustad K. Human heterophilic antibodies display specificity for murine IgG subclasses. Clin Biochem 2005, 38:465-472.
4. Yeo K.T., Storm C.A., Li Y., Jayne J.E., Quinn-Hall KS Brough T., Fitzmaurice T.F. Performance of the enhanced Abbott AxSYM cardiac troponin I reagent in patients with heterophilic antibodies. Clin Chim Acta 2000, 292:13-23.
5. Fleming S.M., O'Byrne L., Finn J., Grimes H., Daly K.M. False-positive cardiac troponin I in a routine clinical population. Am J Cardiol 2002, 89:1212-1215.
6. García-Mancebo M.L., Agulló-Ortuño M.T., Gimeno J.R., Navarro-Martínez M.D., Ruíz-Gómez J., Noguera-Velasco J.A. Heterophile antibodies produce spuriously elevated concentrations of cardiac Troponin I in patients with Legionella pneumophila. Clin Biochem 2005, 38:584-587.
7. Wu A.H.B., Fukushima N., Puskas R., Todd J., Goix P. Development and preliminary clinical validation of a high sensitivity assay for cardiac troponin using a capillary flow (single molecule) fluorescence detector. Clin Chem 2006, 52:2157-2159.
8. Venge P., Johnston N., Lindahl B., James S. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia. J Am Coll Cardiol 2009, 54:1165-1172.
9. Bjerner J., Nustad K., Norum L.F., Olsen K.H., Børmer O.P. Immunometric assay interference: incidence and prevention. Clin Chem 2002, 48:613-621.
10. Ylikotila J., Hellström J.L., Eriksson S., Vehniäinen M., Välimaa L., Takalo H., et al. Utilization of recombinant Fab fragments in a cTnI immunoassay conducted in spot wells. Clin Biochem 2006, 39:843-850.
11. Kuroki M., Matsumoto Y., Arakawa F., Haruno M., Murakami M., Kuwahara M., et al. Reducing interference from heterophilic antibodies in a two-site immunoassay for carcinoembryonic antigen (CEA) by using a human/mouse chimeric antibody to CEA as the tracer. J Immunol Methods 1995, 180:81-91.
12. Järvenpää M.-L., Kuningas K., Niemi I., Hedbeg P., Ristiniemi N., Pettersson K. Rapid and sensitive cardiac troponin I immunoassay based on fluorescent europium(III)-chelated-dyed nanoparticles. Clin Chim Acta 2012, 414:70-75.
13. Härmä H., Soukka T., Lövgren T. Europium nanoparticles and time-resolved fluorescence for ultrasensitive detection of prostate-specific antigen. Clin Chem 2001, 47:561-568.
14. Mukkala V.-M., Hänninen E., Hemmilä I. Synthesis of two biotin isothiocyanate derivatives. 8th European Symposium on Organic Chemistry 1993, 86. Universitat Autnóma de Barcelona, Sitges, Barcelona, Spain.
15. Väisänen V., Peltola M.T., Lilja H., Nurmi M., Pettersson K. Intact free prostate-specific antigen and free and total human glandular kallikrein 2. Elimination of assay interference by enzymatic digestion of antibodies to F(ab')2 fragments. Anal Chem 2006, 78:7809-7815.
16. Eriksson S., Junikka M., Laitinen P., Majamaa-Voltti K., Alfthan H., Pettersson K. Negative interference in cardiac troponin I immunoassays from a frequently occurring serum and plasma component. Clin Chem 2003, 49:1095-1104.
17. Valanne A., Huopalahti S., Soukka T., Vainionpää R., Lövgren T., Härmä H.A. Sensitive adenovirus immunoassay as a model for using nanoparticle label technology in virus diagnostics. J Clin Virol 2005, 33:217-223.
18. von Lode P., Hagren V., Palenius T., Lövgren T. One-step quantitative thyrotropin assay for the detection of hypothyroidism in point-of-care conditions. Clin Biochem 2003, 36:121-128.
19. Eriksson S., Ilva T., Becker C., Lund J., Porela P., Pulkki K., et al. Comparison of cardiac troponin I immunoassays variably affected by circulating autoantibodies. Clin Chem 2005, 51:848-855.
20. Savukoski T., Engstrom E., Engblom J., Ristiniemi N., Wittfooth S., Lindahl B., et al. Troponin-specific autoantibody interference in different cardiac troponin I assay configurations. Clin Chem 2012, 58:1040-1048.
21. Soukka T., Härmä H., Paukkunen J., Lövgren T. Utilization of kinetically enhanced monovalent binding affinity by immunoassays based on multivalent nanoparticle-antibody bioconjugates. Anal Chem 2001, 73:2254-2260.
22. Wu A.H., Akhigbe P., Wians F. Long-term biological variation in cardiac troponin I. Clin Biochem 2012, 45:714-716.
23. Nosanchuk J.S., Combs B., Abbott G. False increases of troponin I attributable to incomplete separation of serum. Clin Chem 1999, 45:714.
24. Krahn J., Parry D.M., Leroux M., Dalton J. High percentage of false positive cardiac troponin I results in patients with rheumatoid factor. Clin Biochem 1999, 32:477-480.
25. Dasgupta A., Banerjee S.K., Datta P. False-positive troponin I in the MEIA due to the presence of rheumatoid factors in serum. Elimination of this interference by using a polyclonal antisera against rheumatoid factors. Am J Clin Pathol 1999, 112:753-756.
26. Börmer O.P. Interference of complement with the binding of carcinoembryonic antigen to solid-phase monoclonal antibodies. J Immunol Methods 1989, 121:85-93.
27. Klee G.G. Human anti-mouse antibodies. Arch Pathol Lab Med 2000, 124:921-923.
28. Gonzales N. Minimizing immunogenicity of the SDR-grafted humanized antibody CC49 by genetic manipulation of the framework residues. Mol Immunol 2003, 40:337-349.
29. Warren D.J., Bjerner J., Paus E., Børmer O.P., Nustad K. Use of an in vivo biotinylated single-chain antibody as capture reagent in an immunometric assay to decrease the incidence of interference from heterophilic antibodies. Clin Chem 2005, 51:830-838.
30. Shimba N., Torigoe H., Takahashi H., Masuda K., Shimada I., Arata Y., et al. Comparative thermodynamic analyses of the Fv, Fab* and Fab fragments of anti-dansyl mouse monoclonal antibody. FEBS Lett 1995, 360:247-250.
31. Hu X., O'Hara L., White S., Magner E., Kane M., Wall J.G. Optimisation of production of a domoic acid-binding scFv antibody fragment in Escherichia coli using molecular chaperones and functional immobilisation on a mesoporous silicate support. Protein Expr Purif 2007, 52:194-201.
32. Eriksson S., Vehniäinen M., Jansen T., Meretoja V., Saviranta P., Pettersson K., et al. Dual-label time-resolved immunofluorometric assay of free and total prostate-specific antigen based on recombinant Fab fragments. Clin Chem 2000, 46:658-666.
33. Venge P., Johnston P., Lagerqvist L., Wallentin L., Lindahl P., FRISC II Study Group Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC-II substudy. Clin Chem 2003, 49:880-886.